Data Flow Chart in a Non-Invasive Breast Cancer Diagnosis System

2007 ◽  
Author(s):  
Mihaela Costin ◽  
Octavian Baltag ◽  
Doina Costandache ◽  
Cipriana Stefanescu
Keyword(s):  
Breast Cancer ◽  
Cancer Diagnosis ◽  
Invasive Breast Cancer ◽  
Data Flow ◽  
Breast Cancer Diagnosis ◽  
Flow Chart ◽  
Diagnosis System ◽  
Non Invasive

scholarly journals Application of FISH Technique in Invasive Breast Cancer Diagnosis

2009 ◽  
Vol 23 (S1) ◽  
Author(s):  
Yasmeen M. Salameh ◽  
Basema I Al‐Kahlout ◽  
Hala W. Bargal ◽  
Nahla M. Afifi
Keyword(s):  
Breast Cancer ◽  
Cancer Diagnosis ◽  
Invasive Breast Cancer ◽  
Breast Cancer Diagnosis ◽  
Fish Technique

Breast malignancy

2021 ◽  
pp. 1025-1052
Author(s):  
Kieran Horgan ◽  
Barbara Dall ◽  
Rebecca Millican-Slater ◽  
Russell Bramhall ◽  
Fiona MacNeill ◽  
...  
Keyword(s):  
Breast Cancer ◽  
United Kingdom ◽  
Cancer Diagnosis ◽  
Invasive Breast Cancer ◽  
Breast Cancer Diagnosis ◽  
Developed Countries ◽  
Western World ◽  
Breast Malignancy ◽  
The United Kingdom

Breast cancer is the commonest cancer to affect women in developed countries and is increasing in frequency in the Western world. Approximately 50,000 women and 400 men are diagnosed with breast cancer in the United Kingdom each year. Eighty per cent of these individuals will survive for at least 5 years after diagnosis. In 2012, 11,762 women died of breast cancer in the United Kingdom. Age-standardized rates of new invasive breast cancer diagnosis have increased from 75 to 126 per 100,000 population in the United Kingdom between 1977 and 2010.

scholarly journals Non-Invasive Biomarkers for Early Detection of Breast Cancer

Cancers ◽  
2020 ◽  
Vol 12 (10) ◽  
pp. 2767
Author(s):  
Jiawei Li ◽  
Xin Guan ◽  
Zhimin Fan ◽  
Lai-Ming Ching ◽  
Yan Li ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Diagnosis ◽  
Early Stage ◽  
False Negative ◽  
Breast Cancer Diagnosis ◽  
Diagnostic Biomarkers ◽  
Circulating Micrornas ◽  
Non Invasive ◽  
Common Cancer ◽  
Volatile Organic

Breast cancer is the most common cancer in women worldwide. Accurate early diagnosis of breast cancer is critical in the management of the disease. Although mammogram screening has been widely used for breast cancer screening, high false-positive and false-negative rates and radiation from mammography have always been a concern. Over the last 20 years, the emergence of “omics” strategies has resulted in significant advances in the search for non-invasive biomarkers for breast cancer diagnosis at an early stage. Circulating carcinoma antigens, circulating tumor cells, circulating cell-free tumor nucleic acids (DNA or RNA), circulating microRNAs, and circulating extracellular vesicles in the peripheral blood, nipple aspirate fluid, sweat, urine, and tears, as well as volatile organic compounds in the breath, have emerged as potential non-invasive diagnostic biomarkers to supplement current clinical approaches to earlier detection of breast cancer. In this review, we summarize the current progress of research in these areas.

scholarly journals Accuracy of administrative databases in detecting primary breast cancer diagnoses: a systematic review

BMJ Open ◽  
2018 ◽  
Vol 8 (7) ◽  
pp. e019264 ◽  
Author(s):  
Iosief Abraha ◽  
Alessandro Montedori ◽  
Diego Serraino ◽  
Massimiliano Orso ◽  
Gianni Giovannini ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Systematic Review ◽  
Cancer Diagnosis ◽  
Invasive Breast Cancer ◽  
Primary Breast Cancer ◽  
Breast Cancer Diagnosis ◽  
Administrative Databases ◽  
Cochrane Library ◽  
Icd 10 ◽  
Incident Cases

ObjectiveTo define the accuracy of administrative datasets to identify primary diagnoses of breast cancer based on the International Classification of Diseases (ICD) 9th or 10th revision codes.DesignSystematic review.Data sources: MEDLINE, EMBASE, Web of Science and the Cochrane Library (April 2017).Eligibility criteriaThe inclusion criteria were: (a) the presence of a reference standard; (b) the presence of at least one accuracy test measure (eg, sensitivity) and (c) the use of an administrative database.Data extractionEligible studies were selected and data extracted independently by two reviewers; quality was assessed using the Standards for Reporting of Diagnostic accuracy criteria.Data analysisExtracted data were synthesised using a narrative approach.ResultsFrom 2929 records screened 21 studies were included (data collection period between 1977 and 2011). Eighteen studies evaluated ICD-9 codes (11 of which assessed both invasive breast cancer (code 174.x) and carcinoma in situ (ICD-9 233.0)); three studies evaluated invasive breast cancer-related ICD-10 codes. All studies except one considered incident cases.The initial algorithm results were: sensitivity ≥80% in 11 of 17 studies (range 57%–99%); positive predictive value was ≥83% in 14 of 19 studies (range 15%–98%) and specificity ≥98% in 8 studies. The combination of the breast cancer diagnosis with surgical procedures, chemoradiation or radiation therapy, outpatient data or physician claim may enhance the accuracy of the algorithms in some but not all circumstances. Accuracy for breast cancer based on outpatient or physician’s data only or breast cancer diagnosis in secondary position diagnosis resulted low.ConclusionBased on the retrieved evidence, administrative databases can be employed to identify primary breast cancer. The best algorithm suggested is ICD-9 or ICD-10 codes located in primary position.Trial registration numberCRD42015026881.

scholarly journals Trends in pre-operative needle biopsy use in invasive breast cancer diagnosis: a Dutch nationwide population study

2020 ◽  
Vol 59 (12) ◽  
pp. 1469-1473
Author(s):  
J. P. Bulte ◽  
D. Simsek ◽  
P. Bult ◽  
J. H. W. de Wilt ◽  
L. J. A. Strobbe
Keyword(s):  
Breast Cancer ◽  
Population Study ◽  
Cancer Diagnosis ◽  
Invasive Breast Cancer ◽  
Needle Biopsy ◽  
Breast Cancer Diagnosis
Sign in / Sign up

Export Citation Format

Share Document